why choose us

300×250 Ad Slot

Research Article: New Uracil Analog with Exocyclic Methylidene Group Can Reverse Resistance to Taxol in MCF- Cancer Cells

Date Published: 2023-05-15

Introduction:
Breast cancer is one of the most prevalent malignancies among women in the world. Over the years, various strategies have been developed for the treatment of this cancer type. The most prevalent therapy includes the combination of surgery with chemotherapy. The drugs that show a significant antitumor activity in breast cancer include drugs such as alkylating agents (cyclophosphamide), antimetabolites (methotrexate), anthracyclines (doxorubicin), an orphan antihypertensive drug (Guanabenz acetate) and the mitotic…

Read more

300×250 Ad Slot